Lifevantage Corporation (LFVN) to Issue Quarterly Dividend of $0.05 on June 15th

Posted by Brian Himes on May 30th, 2026

Lifevantage Corporation (NASDAQ:LFVN – Get Free Report) announced a quarterly dividend on Monday, April 27th. Investors of record on Monday, June 1st will be given a dividend of 0.05 per share on Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, June 1st. This is a 11.1% increase from Lifevantage’s previous quarterly dividend of $0.05.

Lifevantage has a dividend payout ratio of 18.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Lifevantage to earn $0.65 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 30.8%.

Lifevantage Stock Up 3.0%

LFVN opened at $7.90 on Friday. The firm has a market cap of $99.70 million, a P/E ratio of 17.56 and a beta of 0.52. Lifevantage has a 52 week low of $3.90 and a 52 week high of $15.00. The business’s fifty day simple moving average is $5.03 and its 200 day simple moving average is $5.56.

Lifevantage (NASDAQ:LFVN – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. The company had revenue of $43.72 million for the quarter, compared to analyst estimates of $47.77 million. As a group, equities analysts expect that Lifevantage will post 0.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Weiss Ratings raised Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday. Lake Street Capital lowered Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target on the stock. in a research note on Thursday, May 7th. Finally, Loop Capital set a $5.00 price target on Lifevantage in a research note on Thursday, February 5th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $5.00.

Read Our Latest Stock Analysis on Lifevantage

Lifevantage Company Profile

(Get Free Report)

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.